About this trial
In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with chronic spinal cord injury 6 months after receiving the award
Patients with confirmed AD due to bladder fullness in previous urodynamic test
Patients confirmed to have neurological damage level C1-T6, AIS A or B
Disqualifiers
Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test
Patients who cannot undergo testing due to hemodynamic instability
Patients who cannot undergo testing due to overt urinary tract infection
Trial population
Chronic spinal cord injuries
Trial design
Case-only
Prospective
Treatments tested in this trial
Urodynamic test
Other interventionUrodynamic testing is performed using saline solution at the same temperature as body temperature (37 degrees) at two injection speeds of 10 mL/min and 100 mL/min, respectively.
Treatment groups
Trial outcomes
Primary outcomes
Bladder volume (ml)
(1) at first AD at an infusion rate of 10 mL/min (2) at first AD at an infusion rate of 100 mL/min
Secondary outcomes
Bladder compliance (mL/cmH2O)
Bladder compliance
Symptoms (Y/N)
Symptoms
Blood pressure (mmHg)
Blood pressure
Heart rate (bpm)
Heart rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.